HomeNationBharat Biotech seeks DCGI's nod to conduct trials of nasal COVID-19 vaccine

Bharat Biotech seeks DCGI’s nod to conduct trials of nasal COVID-19 vaccine

@the_news_21

The Bharat Biotech International Limited has sent a proposal to the Drugs Controller General of India (DCGI) for conducting the phase 1 trials of a nasal vaccine against COVID-19, informed a government official on Friday.

“Bharat Biotech sent an application to DCGI for conducting the phase 1 trials of a nasal vaccine against COVID-19. The matter is yet to be taken up,” the official said.

A nasal vaccine could save on medical equipment, such as syringes, and save time taken for vaccination.

COVID-19 vaccines of Serum Institute of India’s ‘Covishield’ and Bharat Biotech’s ‘Covaxin’ were granted permission for restricted use in an emergency situation by the DCGI on January 3.

This comes a day after Bharat Biotech announced the successful completion of volunteer enrolment for phase-3 clinical trials of ‘Covaxin.’ The indigenous vaccine has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).

COVAXIN has been evaluated in approximately 1,000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results, with acceptance in international peer-reviewed scientific journals, the company had said in a statement.

COVAXIN is a highly purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with an excellent safety track record of more than 300 million doses, it had added.

Union Health Minister Dr Harsh Vardhan had asserted that the COVID-19 vaccines ‘Covishield’ and ‘Covaxin’ are on the verge of being available in the country.

Subscribe to TheNews21

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

35 COMMENTS

  1. Dive into DraftKings exclusive games Casino today and claim your epic welcome package! Play just $5 to unlock 500 exciting spins on Cash Eruption games plus up to $1,000 back in credits if luck isn’t on your side in the first 24 hours. Experience top slots, live tables, and exclusive games—your crown awaits!

  2. Connect the millions winning momentous on fanduel casino Montana – the #1 legitimate in dough casino app in America.
    Pick up your $1000 PLAY IT AGAIN hand-out and deny b decrease every spin, hand and roll into legitimate coin of the realm rewards.
    Irresponsibly payouts, immense jackpots, and non-stop fight – download FanDuel Casino in these times and start playing like a pro today!

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img

@the_news_21

The Bharat Biotech International Limited has sent a proposal to the Drugs Controller General of India (DCGI) for conducting the phase 1 trials of a nasal vaccine against COVID-19, informed a government official on Friday.

“Bharat Biotech sent an application to DCGI for conducting the phase 1 trials of a nasal vaccine against COVID-19. The matter is yet to be taken up,” the official said.

A nasal vaccine could save on medical equipment, such as syringes, and save time taken for vaccination.

COVID-19 vaccines of Serum Institute of India’s ‘Covishield’ and Bharat Biotech’s ‘Covaxin’ were granted permission for restricted use in an emergency situation by the DCGI on January 3.

This comes a day after Bharat Biotech announced the successful completion of volunteer enrolment for phase-3 clinical trials of ‘Covaxin.’ The indigenous vaccine has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).

COVAXIN has been evaluated in approximately 1,000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results, with acceptance in international peer-reviewed scientific journals, the company had said in a statement.

COVAXIN is a highly purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with an excellent safety track record of more than 300 million doses, it had added.

Union Health Minister Dr Harsh Vardhan had asserted that the COVID-19 vaccines ‘Covishield’ and ‘Covaxin’ are on the verge of being available in the country.

Html code here! Replace this with any non empty text and that's it.

35 COMMENTS

  1. Dive into DraftKings exclusive games Casino today and claim your epic welcome package! Play just $5 to unlock 500 exciting spins on Cash Eruption games plus up to $1,000 back in credits if luck isn’t on your side in the first 24 hours. Experience top slots, live tables, and exclusive games—your crown awaits!

  2. Connect the millions winning momentous on fanduel casino Montana – the #1 legitimate in dough casino app in America.
    Pick up your $1000 PLAY IT AGAIN hand-out and deny b decrease every spin, hand and roll into legitimate coin of the realm rewards.
    Irresponsibly payouts, immense jackpots, and non-stop fight – download FanDuel Casino in these times and start playing like a pro today!

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img